SlideShare a Scribd company logo
1 of 11
CaP particle stimulation of dendritic cells for
vaccine development
Stephen Braunewell
Wake Forest University
2014 College Intern
Immunotope, Inc.
Cell mediated immunity begins with antigen processing
• Endogenously biosynthesized antigen
• CD8 T Cell Activation
• Exogenous/extracellular antigen
• CD4 T Cell Activation
Parham 2006
DC activating T cell
O’Hagan and Valiante 2003
My Project
• The goal: Determine if Calcium phosphate nanoparticles are capable of inducing
dendritic cell maturation
• Readout: Expression of cell surface proteins on dendritic cell that are key to T cell
activation.
• MHC Class I, Class II, CD80, and CD86 molecules on cell surface.
• Importance: Up regulation of these molecules are vital in the production of potent
vaccines.
Procedure
Harvest DC’s (DC2.4 or Primary)
Feed into 12 well plate
DC2.4
(M
ouse)
Prim
ary
(H
um
an)
Add CaP Add CaP
Flow cytometry and cytokine
analysis (MagPix)
Flow cytometry
2hrs, 4 hrs and 24 hrs later24 hrs later
1 x 10e6 cells per well
0.5 x 10e6 cells per well
CaP Induced Maturation of DC 2.4s
DC 2.4: Ab
0
10
20
30
40
50
60
70
80
90
100
None 80uL 160uL LPS
MFI
DC 2.4: Kb
0
10
20
30
40
50
60
70
None 80uL 160uL LPS
MFI
DC 2.4: CD80
0
10
20
30
40
50
60
70
80
90
None 80uL 160uL LPS
MFI
DC 2.4: CD86
0
50
100
150
200
250
300
350
400
450
None 80uL 160uL LPS
MFI
Primary DC: Class II
0
20
40
60
80
100
120
140
160
None 80uL of CaP
Only
80uL of CaP
+Peptide
LPS
MFI
CaP Induced Maturation of Primary DCs
Primary DC: Class I
0
20
40
60
80
None 80uL ofCaP Only 80uL ofCaP
+Peptide
LPS
MFI
Primary DC: CD86
0
20
40
60
80
100
120
None 80uL of CaP
Only
80uL of CaP
+Peptide
LPS
MFI
CaP Induced Maturation of Primary DCs
CaP Induced Cytokine Secretion
Conclusion/Next Steps
• CaP nano particles have potential to be a useful adjuvant in the creation of more
potent vaccines.
• Next step would be to repeat this assay and see if there is statistical significance in
the data.
• Test nanoparticles using T cell activation assays.
Lessons/Techniques Learned
• Cell culture
• Flow Cytometry
• MagPix
• Immune system information
Acknowledgments
A huge thank you to everyone who made this experience possible:
Immunotope
Ramilia Philip, PhD
Joseph Comber, PhD
Aykan Karabudak
Xiaofang Huang, PhD
Tulin Morcol, PhD
Hepatitis B Foundation
Timothy Block, PhD
Pamela Norton, PhD
Peggy Farley, MBA
Joan Block, RN, BSN

More Related Content

Viewers also liked

(286)long deficit fiscal_¿que deficit?
(286)long  deficit fiscal_¿que deficit?(286)long  deficit fiscal_¿que deficit?
(286)long deficit fiscal_¿que deficit?Deusto Business School
 
Rtm 108.021.102 85
Rtm 108.021.102 85Rtm 108.021.102 85
Rtm 108.021.102 85usign787
 
Academia dancing
Academia dancingAcademia dancing
Academia dancingfjpozpor
 
REVOLUCION INDUSTRIAL INGLATERRRA SXVIII. CAUSAS Y CONSECUENCIAS
REVOLUCION INDUSTRIAL INGLATERRRA SXVIII. CAUSAS Y CONSECUENCIASREVOLUCION INDUSTRIAL INGLATERRRA SXVIII. CAUSAS Y CONSECUENCIAS
REVOLUCION INDUSTRIAL INGLATERRRA SXVIII. CAUSAS Y CONSECUENCIASDejavuihs
 
09 tabgha bienaventuranzas
09 tabgha bienaventuranzas09 tabgha bienaventuranzas
09 tabgha bienaventuranzasclasesteologia
 
Tema 8. sociales, presentación
Tema 8. sociales, presentaciónTema 8. sociales, presentación
Tema 8. sociales, presentaciónesthergarcia2014
 
¿QUE SIGNIFICA EL CONCIERTO ECONOMICO VASCO?
¿QUE SIGNIFICA EL CONCIERTO ECONOMICO VASCO?¿QUE SIGNIFICA EL CONCIERTO ECONOMICO VASCO?
¿QUE SIGNIFICA EL CONCIERTO ECONOMICO VASCO?Deusto Business School
 
The causes and risk-taking on the change of CEO equity-based compensation
The causes and risk-taking on the change of CEO equity-based compensationThe causes and risk-taking on the change of CEO equity-based compensation
The causes and risk-taking on the change of CEO equity-based compensationMax Lai
 
Genres of Documentaries
Genres of DocumentariesGenres of Documentaries
Genres of DocumentariesGeorgiaLBarker
 
Horsch Terrano FG parts catalog
Horsch Terrano FG parts catalogHorsch Terrano FG parts catalog
Horsch Terrano FG parts catalogPartCatalogs Net
 
Chu trinh lanh 2 cap su dung binh trung gian ong xoan
Chu trinh lanh 2 cap su dung binh trung gian ong xoanChu trinh lanh 2 cap su dung binh trung gian ong xoan
Chu trinh lanh 2 cap su dung binh trung gian ong xoanTuan Vu
 

Viewers also liked (12)

(286)long deficit fiscal_¿que deficit?
(286)long  deficit fiscal_¿que deficit?(286)long  deficit fiscal_¿que deficit?
(286)long deficit fiscal_¿que deficit?
 
Ciencias sociales
Ciencias socialesCiencias sociales
Ciencias sociales
 
Rtm 108.021.102 85
Rtm 108.021.102 85Rtm 108.021.102 85
Rtm 108.021.102 85
 
Academia dancing
Academia dancingAcademia dancing
Academia dancing
 
REVOLUCION INDUSTRIAL INGLATERRRA SXVIII. CAUSAS Y CONSECUENCIAS
REVOLUCION INDUSTRIAL INGLATERRRA SXVIII. CAUSAS Y CONSECUENCIASREVOLUCION INDUSTRIAL INGLATERRRA SXVIII. CAUSAS Y CONSECUENCIAS
REVOLUCION INDUSTRIAL INGLATERRRA SXVIII. CAUSAS Y CONSECUENCIAS
 
09 tabgha bienaventuranzas
09 tabgha bienaventuranzas09 tabgha bienaventuranzas
09 tabgha bienaventuranzas
 
Tema 8. sociales, presentación
Tema 8. sociales, presentaciónTema 8. sociales, presentación
Tema 8. sociales, presentación
 
¿QUE SIGNIFICA EL CONCIERTO ECONOMICO VASCO?
¿QUE SIGNIFICA EL CONCIERTO ECONOMICO VASCO?¿QUE SIGNIFICA EL CONCIERTO ECONOMICO VASCO?
¿QUE SIGNIFICA EL CONCIERTO ECONOMICO VASCO?
 
The causes and risk-taking on the change of CEO equity-based compensation
The causes and risk-taking on the change of CEO equity-based compensationThe causes and risk-taking on the change of CEO equity-based compensation
The causes and risk-taking on the change of CEO equity-based compensation
 
Genres of Documentaries
Genres of DocumentariesGenres of Documentaries
Genres of Documentaries
 
Horsch Terrano FG parts catalog
Horsch Terrano FG parts catalogHorsch Terrano FG parts catalog
Horsch Terrano FG parts catalog
 
Chu trinh lanh 2 cap su dung binh trung gian ong xoan
Chu trinh lanh 2 cap su dung binh trung gian ong xoanChu trinh lanh 2 cap su dung binh trung gian ong xoan
Chu trinh lanh 2 cap su dung binh trung gian ong xoan
 

Similar to CaP Particle Presentation

HIV biology and isolation of RT inhibitor from plant
HIV biology and isolation of RT inhibitor from plantHIV biology and isolation of RT inhibitor from plant
HIV biology and isolation of RT inhibitor from plantTitas Mallick
 
Webinar Slide - MetMax Hepatocytes and Enterocytes 09-20-17
Webinar Slide - MetMax Hepatocytes and Enterocytes 09-20-17Webinar Slide - MetMax Hepatocytes and Enterocytes 09-20-17
Webinar Slide - MetMax Hepatocytes and Enterocytes 09-20-17Veronica Huang, PhD
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...MilliporeSigma
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Merck Life Sciences
 
WESTERN BLOTTING ADYA.pptx
WESTERN BLOTTING ADYA.pptxWESTERN BLOTTING ADYA.pptx
WESTERN BLOTTING ADYA.pptxAADYARAJPANDEY1
 
Accelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesAccelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesMilliporeSigma
 
Accelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesAccelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesMerck Life Sciences
 
Oligonucleotide Capabilities at Pine Lake Laboratories
Oligonucleotide Capabilities at Pine Lake LaboratoriesOligonucleotide Capabilities at Pine Lake Laboratories
Oligonucleotide Capabilities at Pine Lake LaboratoriesPine Lake Laboratories
 
CAR-T Cell Products Validation
CAR-T Cell Products ValidationCAR-T Cell Products Validation
CAR-T Cell Products ValidationCreative-Biolabs
 
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...Merck Life Sciences
 
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...MilliporeSigma
 
KIPER_SCTRP_Presentation
KIPER_SCTRP_PresentationKIPER_SCTRP_Presentation
KIPER_SCTRP_PresentationKeturah Kiper
 
Anticancer activity of withania somnifera on h ep 2 cell
Anticancer activity of withania somnifera on h ep 2 cellAnticancer activity of withania somnifera on h ep 2 cell
Anticancer activity of withania somnifera on h ep 2 cellSamayaditya Singh
 
antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)Stephanie Thiede
 
Slides faod - the other mitochondrial energy diseases - vockley
Slides   faod - the other mitochondrial energy diseases - vockleySlides   faod - the other mitochondrial energy diseases - vockley
Slides faod - the other mitochondrial energy diseases - vockleymitoaction
 
Pfizer Black Swan 2019 2 (002).pptx
Pfizer Black Swan 2019 2 (002).pptxPfizer Black Swan 2019 2 (002).pptx
Pfizer Black Swan 2019 2 (002).pptxRamyRamzy10
 

Similar to CaP Particle Presentation (20)

HIV biology and isolation of RT inhibitor from plant
HIV biology and isolation of RT inhibitor from plantHIV biology and isolation of RT inhibitor from plant
HIV biology and isolation of RT inhibitor from plant
 
Valitacell Technology
Valitacell TechnologyValitacell Technology
Valitacell Technology
 
Webinar Slide - MetMax Hepatocytes and Enterocytes 09-20-17
Webinar Slide - MetMax Hepatocytes and Enterocytes 09-20-17Webinar Slide - MetMax Hepatocytes and Enterocytes 09-20-17
Webinar Slide - MetMax Hepatocytes and Enterocytes 09-20-17
 
3.i
3.i3.i
3.i
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...
 
Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...Investing in Process Development for Increased MSC Production in Stirred Tank...
Investing in Process Development for Increased MSC Production in Stirred Tank...
 
WESTERN BLOTTING ADYA.pptx
WESTERN BLOTTING ADYA.pptxWESTERN BLOTTING ADYA.pptx
WESTERN BLOTTING ADYA.pptx
 
Accelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesAccelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell Lines
 
Accelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell LinesAccelerate Delivery of High Producing Cell Lines
Accelerate Delivery of High Producing Cell Lines
 
Oligonucleotide Capabilities at Pine Lake Laboratories
Oligonucleotide Capabilities at Pine Lake LaboratoriesOligonucleotide Capabilities at Pine Lake Laboratories
Oligonucleotide Capabilities at Pine Lake Laboratories
 
Thireault_Presentation_17Jul2008_ver 1
Thireault_Presentation_17Jul2008_ver 1Thireault_Presentation_17Jul2008_ver 1
Thireault_Presentation_17Jul2008_ver 1
 
CAR-T Cell Products Validation
CAR-T Cell Products ValidationCAR-T Cell Products Validation
CAR-T Cell Products Validation
 
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
 
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
Risk Mitigation in Cell Line Development: Regulatory Considerations and Impac...
 
Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
 Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p... Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
 
KIPER_SCTRP_Presentation
KIPER_SCTRP_PresentationKIPER_SCTRP_Presentation
KIPER_SCTRP_Presentation
 
Anticancer activity of withania somnifera on h ep 2 cell
Anticancer activity of withania somnifera on h ep 2 cellAnticancer activity of withania somnifera on h ep 2 cell
Anticancer activity of withania somnifera on h ep 2 cell
 
antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)antigen presentation machinery in ctcs (1)
antigen presentation machinery in ctcs (1)
 
Slides faod - the other mitochondrial energy diseases - vockley
Slides   faod - the other mitochondrial energy diseases - vockleySlides   faod - the other mitochondrial energy diseases - vockley
Slides faod - the other mitochondrial energy diseases - vockley
 
Pfizer Black Swan 2019 2 (002).pptx
Pfizer Black Swan 2019 2 (002).pptxPfizer Black Swan 2019 2 (002).pptx
Pfizer Black Swan 2019 2 (002).pptx
 

CaP Particle Presentation

  • 1. CaP particle stimulation of dendritic cells for vaccine development Stephen Braunewell Wake Forest University 2014 College Intern Immunotope, Inc.
  • 2. Cell mediated immunity begins with antigen processing • Endogenously biosynthesized antigen • CD8 T Cell Activation • Exogenous/extracellular antigen • CD4 T Cell Activation Parham 2006
  • 3. DC activating T cell O’Hagan and Valiante 2003
  • 4. My Project • The goal: Determine if Calcium phosphate nanoparticles are capable of inducing dendritic cell maturation • Readout: Expression of cell surface proteins on dendritic cell that are key to T cell activation. • MHC Class I, Class II, CD80, and CD86 molecules on cell surface. • Importance: Up regulation of these molecules are vital in the production of potent vaccines.
  • 5. Procedure Harvest DC’s (DC2.4 or Primary) Feed into 12 well plate DC2.4 (M ouse) Prim ary (H um an) Add CaP Add CaP Flow cytometry and cytokine analysis (MagPix) Flow cytometry 2hrs, 4 hrs and 24 hrs later24 hrs later 1 x 10e6 cells per well 0.5 x 10e6 cells per well
  • 6. CaP Induced Maturation of DC 2.4s DC 2.4: Ab 0 10 20 30 40 50 60 70 80 90 100 None 80uL 160uL LPS MFI DC 2.4: Kb 0 10 20 30 40 50 60 70 None 80uL 160uL LPS MFI DC 2.4: CD80 0 10 20 30 40 50 60 70 80 90 None 80uL 160uL LPS MFI DC 2.4: CD86 0 50 100 150 200 250 300 350 400 450 None 80uL 160uL LPS MFI
  • 7. Primary DC: Class II 0 20 40 60 80 100 120 140 160 None 80uL of CaP Only 80uL of CaP +Peptide LPS MFI CaP Induced Maturation of Primary DCs Primary DC: Class I 0 20 40 60 80 None 80uL ofCaP Only 80uL ofCaP +Peptide LPS MFI Primary DC: CD86 0 20 40 60 80 100 120 None 80uL of CaP Only 80uL of CaP +Peptide LPS MFI
  • 8. CaP Induced Maturation of Primary DCs
  • 10. Conclusion/Next Steps • CaP nano particles have potential to be a useful adjuvant in the creation of more potent vaccines. • Next step would be to repeat this assay and see if there is statistical significance in the data. • Test nanoparticles using T cell activation assays. Lessons/Techniques Learned • Cell culture • Flow Cytometry • MagPix • Immune system information
  • 11. Acknowledgments A huge thank you to everyone who made this experience possible: Immunotope Ramilia Philip, PhD Joseph Comber, PhD Aykan Karabudak Xiaofang Huang, PhD Tulin Morcol, PhD Hepatitis B Foundation Timothy Block, PhD Pamela Norton, PhD Peggy Farley, MBA Joan Block, RN, BSN